Skip to main content
    I

    IRIDEX Corporation (IRIX)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $0.69
    -0.00 (-0.32%)

    Market Cap: $12.12M

    Last updated: Nov 17, 2026 at 10:43 AM ET

    IRIDEX Corporation (IRIX) Financials: Revenue, Profit and Cash Flow

    Updated Aug 18, 2026. Financial statements from company filings, amounts in US dollars.

    IRIDEX reported revenue of $52.67M for the fiscal year ended Dec 31, 2025, up 8.2% from the year before. That year, net income was -$4.44M with a net margin of -8.4%, operating cash flow was -$2.12M and free cash flow was -$2.26M. The quarter ended Jun 30, 2026 had revenue of $12.57M and net income of -$1.27M.

    Revenue and Margins

    The operating margin was -4.9% in the fiscal year ended Dec 2025, the highest of the 10 years shown. Over the 9 years to Dec 2025, revenue grew from $46.16M, a compound annual rate of 1.5%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$52.67M+8.2%36.7%-4.9%-8.4%
    Dec 2024$48.67M-6.2%40.1%-17.1%-18.3%
    Dec 2023$51.87M-9.0%42.0%-19.3%-18.5%
    Dec 2022$56.97M+5.7%44.5%-13.2%-13.2%
    Dec 2021$53.90M+48.3%42.4%-14.0%-9.7%
    Dec 2020$36.35M-16.3%42.8%-18.1%-17.4%
    Dec 2019$43.45M+2.0%41.3%-20.7%-20.3%
    Dec 2018$42.60M+2.4%41.0%-30.2%-30.1%
    Dec 2017$41.59M-9.9%37.3%-31.0%-30.9%
    Dec 2016$46.16MN/A45.1%-5.6%-25.4%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss narrowed from the year before. In the quarter ended Jun 2026, the net loss widened from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$52.67M$48.67M$51.87M$56.97M$53.90M$36.35M$43.45M$42.60M$41.59M$46.16M
    Cost of revenue$33.37M$29.17M$30.06M$31.60M$31.07M$20.79M$25.51M$25.13M$26.09M$25.32M
    Gross profit$19.31M$19.50M$21.81M$25.37M$22.83M$15.56M$17.94M$17.47M$15.50M$20.84M
    Research and development$3.67M$5.45M$6.83M$7.17M$6.87M$3.28M$3.68M$4.01M$5.73M$5.37M
    Operating income-$2.57M-$8.30M-$10.01M-$7.54M-$7.53M-$6.58M-$8.97M-$12.87M-$12.89M-$2.56M
    Net income-$4.44M-$8.91M-$9.57M-$7.55M-$5.22M-$6.33M-$8.81M-$12.81M-$12.87M-$11.71M
    EBITDAN/A-$7.42M-$7.45M-$6.16M-$6.73M-$6.08M-$8.29M-$12.06M-$12.17M-$1.80M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Revenue$12.57M$11.80M$14.72M$12.48M$13.57M$11.90M$12.70M$11.58M$12.63M$11.76M$12.46M$12.85M
    Gross profit$4.30M$4.74M$5.63M$4.01M$4.60M$5.05M$5.59M$4.32M$5.13M$4.37M$4.80M$5.62M
    Operating income-$1.03M-$324.00K-$15.00K-$1.41M-$940.00K-$205.00K-$502.00K-$1.87M-$2.64M-$3.29M-$3.08M-$1.69M
    Net income-$1.27M-$524.00K-$184.00K-$1.57M-$994.00K-$1.69M-$834.00K-$1.93M-$2.68M-$3.46M-$2.96M-$1.75M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded total debt of $4.43M by $1.59M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$29.15M$29.14M$34.44M$42.29M$48.69M$27.97M$34.81M$41.67M$41.65M$48.14M
    Current assets$25.25M$23.56M$27.45M$35.77M$42.25M$25.36M$30.55M$39.62M$39.45M$45.87M
    Cash and equivalents$6.03M$2.39M$7.03M$13.92M$23.85M$11.63M$12.65M$21.19M$21.71M$23.75M
    Total liabilities$24.23M$27.04M$24.91M$25.06M$25.39M$10.60M$12.11M$11.71M$11.12M$8.98M
    Short-term debt$699.00K$2.83M$995.00K$1.04M$927.00K$2.66M$1.41M$26.00K$566.00K$590.00K
    Long-term debt$3.73M$1.00MN/AN/AN/A$1.25MN/AN/A$0$0
    Shareholder equity$4.92M$2.10M$9.52M$17.23M$23.30M$17.37M$22.70M$29.96M$30.52M$39.16M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total assets$27.26M$28.27M$29.15M$28.35M$31.59M$34.24M$29.14M$30.15M$31.25M$34.09M$34.44M$34.95M
    Total liabilities$23.62M$23.54M$24.23M$23.67M$25.53M$33.38M$27.04M$27.53M$27.00M$27.60M$24.91M$22.89M
    Cash and equivalents$4.68M$4.59M$6.03M$5.57M$6.78M$7.24M$2.39M$3.86M$4.11M$5.42M$7.03M$7.98M
    Shareholder equity$3.64M$4.73M$4.92M$4.68M$6.06M$852.00K$2.10M$2.62M$4.25M$6.49M$9.52M$12.06M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow-$2.12M-$7.29M-$6.75M-$9.52M$8.22M-$3.24M-$7.91M-$10.03M-$3.56M-$144.00K
    Capital expenditures$143.00K$13.00K$109.00K$286.00K$213.00K$97.00K$128.00K$440.00K$575.00K$1.06M
    Free cash flow-$2.26M-$7.30M-$6.85M-$9.80M$8.00M-$3.33M-$8.04M-$10.46M-$4.14M-$1.21M
    Investing cash flow-$143.00K-$13.00K-$109.00K-$286.00K-$5.56M-$93.00K-$509.00K-$827.00K-$782.00K-$1.47M
    Financing cash flow$5.96M$2.60M-$5.00K-$73.00K$9.47M$2.47M-$156.00K$10.38M$2.31M$15.36M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Operating cash flow$174.00K-$1.33M$589.00K-$1.16M-$397.00K-$1.15M-$1.24M-$3.07M-$1.33M-$1.65M-$979.00K-$1.78M
    Capital expenditures$50.00K$101.00K$106.00K$13.00K$13.00K$11.00K$9.00K$1.00K$0$3.00K$32.00K$82.00K
    Free cash flow$124.00K-$1.44M$483.00K-$1.17M-$410.00K-$1.16M-$1.25M-$3.07M-$1.33M-$1.65M-$1.01M-$1.86M
    Last 12 quarters

    Frequently Asked Questions About IRIX

    What is IRIDEX's annual revenue?

    IRIDEX reported revenue of $52.67M for the fiscal year ended Dec 31, 2025.

    How fast is IRIDEX's revenue growing?

    Revenue was up 8.2% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -2.6%.

    Is IRIDEX profitable?

    No. IRIDEX reported net income of -$4.44M for the fiscal year ended Dec 31, 2025, with a net margin of -8.4%.

    How much free cash flow does IRIX generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$2.12M minus capital expenditures of $143.00K produced free cash flow of -$2.26M.

    How much debt does IRIDEX have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $3.73M, short-term debt of $699.00K and cash and equivalents of $6.03M.